Insider Trading June 29, 2026 03:09 PM

TTM Technologies CFO Executes Pre-Arranged Share Sale Amid Strategic Expansion

Daniel Boehle disposes of shares under 10b5-1 plan as the company prepares for Russell 1000 inclusion and key acquisitions.

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
TTMI

TTM Technologies Inc. (NASDAQ:TTMI) Executive Vice President and Chief Financial Officer Daniel L. Boehle recently completed a share disposal valued at $881,290 on June 25, 2026. The transaction, executed under a pre-arranged 10b5-1 trading plan, was designated to cover tax liabilities associated with restricted stock unit vesting. Following the sale, Boehle retains a direct holding of 75,055 shares in the company. This financial activity occurs against a backdrop of significant corporate developments for TTM Technologies, including a planned migration to the Russell 1000 Index and strategic acquisitions aimed at strengthening its position in the medical, aerospace, and defense sectors.

TTM Technologies CFO Executes Pre-Arranged Share Sale Amid Strategic Expansion
TTMI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • TTM Technologies CFO Daniel Boehle sold 4,218 shares worth $881,290 under a 10b5-1 plan to cover tax liabilities.
  • The company is migrating to the Russell 1000 Index, reflecting significant growth in market capitalization.
  • TTM Technologies is acquiring Swiss Technology Group AG and ILFA GmbH to enhance capabilities in medical, aerospace, and defense sectors.

TTM Technologies Inc. (NASDAQ:TTMI) Executive Vice President and Chief Financial Officer Daniel L. Boehle executed a share disposal totaling $881,290 on June 25, 2026, according to recent Securities and Exchange Commission filings. The transaction involved the sale of 4,218 shares of common stock at prices ranging from $203.68 to $218.27 per share. These sales were conducted under the guidelines of a pre-arranged 10b5-1 trading plan, which was adopted on February 24, 2026, specifically to manage tax obligations linked to the vesting of restricted stock units. Post-transaction, Mr. Boehle maintains a direct ownership stake of 75,055 shares of TTM Technologies common stock.


The timing of this executive sale follows a period of notable volatility for TTMI shares. The stock has experienced a 13.5% decline over the past week, contrasting sharply with a 376% surge recorded over the past year. Market analysis from InvestingPro suggests that TTMI currently trades at a valuation premium relative to its calculated Fair Value. Subscribers to the service have access to 19 additional ProTips for deeper insight into the stock's metrics.


Key Points

  • Strategic Index Migration: TTM Technologies has announced its intention to migrate from the Russell 2000 Index to the Russell 1000 Index, effective after market close. This transition reflects a substantial increase in market capitalization, positioning the company among the largest publicly traded entities in the United States.
  • Targeted Acquisitions: The company is proceeding with plans to acquire Swiss Technology Group AG and ILFA GmbH through separate all-cash transactions, pending regulatory approvals. These acquisitions are designed to enhance TTM's operational capabilities within the medical, aerospace, and defense sectors.
  • Manufacturing Expansion: TTM Technologies has inaugurated a new $130 million Ultra-High-Density Interconnect printed circuit board manufacturing facility in Syracuse, New York. Partially funded by the U.S. Department of Defense, this plant will focus on producing advanced circuit boards for aerospace and defense applications. Additionally, the company's Mini-Xinger product portfolio has secured AEC-Q200 qualification accreditation, validating its suitability for automotive and high-reliability applications.

Risks and Uncertainties

  • Regulatory Approval Dependencies: The successful completion of the acquisitions of Swiss Technology Group AG and ILFA GmbH remains contingent upon receiving necessary regulatory approvals. Any delays or denials could impact the company's strategic growth trajectory in the medical, aerospace, and defense sectors.
  • Valuation Discrepancies: Current market data indicates that TTMI is trading at a premium to its Fair Value, as highlighted by InvestingPro analysis. This valuation gap may suggest potential volatility or a correction risk for investors monitoring the stock's performance relative to intrinsic value metrics.
  • Market Capitalization Shifts: The transition from the Russell 2000 to the Russell 1000 Index signifies a major shift in the company's market classification. While indicative of growth, such migrations can alter investor composition and liquidity dynamics, potentially impacting short-term price stability.

These developments underscore TTM Technologies' ongoing strategic expansion and its focus on advancing technological capabilities across critical industrial sectors. The combination of executive transactions, index migration, and targeted acquisitions highlights the company's efforts to solidify its market position amid evolving industry demands.

Risks

  • Acquisitions of Swiss Technology Group AG and ILFA GmbH are subject to regulatory approvals, introducing execution uncertainty.
  • Current analysis suggests TTMI may be overvalued relative to its Fair Value, indicating potential valuation risks.
  • Index migration from Russell 2000 to Russell 1000 may alter investor dynamics and market perception.

More from Insider Trading

Oscar Health CEO Mark Bertolini Executes $34.9 Million Stock Sale Jun 29, 2026 Workday Founder David A. Duffield Executes $12.4 Million Share Sale Under Pre-Arranged Plan Jun 29, 2026 Phio Pharmaceuticals CEO Robert Bitterman Acquires $9,900 in Company Shares Jun 29, 2026 Mission Produce CFO Executes $60,650 Stock Sale Amid Mixed Financial Signals Jun 29, 2026 TTM Technologies COO James P. Walsh Executes $441,481 Stock Sale Under Pre-Arranged Plan Jun 29, 2026